Puma Biotechnology (PBYI) Capital Expenditures (2011 - 2025)
Puma Biotechnology (PBYI) reported Capital Expenditures of -$102000.0 for Q4 2025, down 410.0% on a YoY basis from $32903.2 in Q4 2024, and down 492.31% quarter-over-quarter from $26000.0 in Q3 2025.
Puma Biotechnology (PBYI) Capital Expenditures (2011 - 2025) Analysis & Trends
Puma Biotechnology has reported Capital Expenditures for 13 years, with the latest figure at -$102000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 410.0% year-over-year to -$102000.0; the trailing twelve-month figure through Mar 2026 stood at -$56000.0 (down 191.8% YoY), and the FY2025 full-year result was $5000.0, changed N/A from the prior year.
- Capital Expenditures for Q4 2025 stood at -$102000.0, down from $26000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $7.0 million in Q3 2022, with the low at -$7.0 million in Q4 2022.
- Historically, Capital Expenditures has averaged $1454.5 across 4 years, with a median of $10000.0 in 2024.
- The largest YoY upside for Capital Expenditures was 160.0% in 2025 against a maximum downside of 410.0% in 2025.
- Puma Biotechnology's Capital Expenditures stood at -$7.0 million in 2022, then surged by 99.01% to -$69000.0 in 2023, then surged by 71.01% to -$20000.0 in 2024, then sank by 410.0% to -$102000.0 in 2025.
- The last three Capital Expenditures figures came in at -$102000.0 (Q4 2025), $26000.0 (Q3 2025), and $20000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -102,000.00 |
| Dec 31, 2025 | -102,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Sep 30, 2023 | 80,000.00 |
| Sep 30, 2023 | 80,000.00 |
| Dec 31, 2022 | -7.00 Mn |
| Dec 31, 2022 | -7.00 Mn |